Minimally invasive aortic valve replacement: short-term efficacy of sutureless compared with stented bioprostheses.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
26 07 2021
Historique:
received: 16 12 2020
revised: 23 01 2021
accepted: 24 01 2021
pubmed: 14 5 2021
medline: 25 11 2021
entrez: 13 5 2021
Statut: ppublish

Résumé

Sutureless aortic valve prostheses have been introduced to facilitate the implant process, speed up the operating time and improve haemodynamic performance. The goal of this study was to assess the potential advantages of using sutureless prostheses during minimally invasive aortic valve replacement in a large multicentre population. From 2011 to 2019, a total of 3402 patients in 11 hospitals underwent isolated aortic valve replacement with minimal access approaches using a bioprosthesis. A total of 475 patients received sutureless valves; 2927 received standard valves. The primary outcome was the incidence of 30-day deaths. Secondary outcomes were the occurrence of major complications following procedures performed with sutureless or standard bioprostheses. Propensity matched comparisons was performed based on a multivariable logistic regression model. The annual number of sutureless valve implants increased over the years. The matching procedure paired 430 sutureless with 860 standard aortic valve replacements. A total of 0.7% and 2.1% patients with sutureless and standard prostheses, respectively, died within 30 days (P = 0.076). Cross-clamp times [48 (40-62) vs 63 min (48-74); P = 0.001] and need for blood transfusions (27.4% vs 33.5%; P = 0.022) were lower in patients with sutureless valves. No difference in permanent pacemaker insertions was observed in the overall population (3.3% vs 4.4% in the standard and sutureless groups; P = 0.221) and in the matched groups (3.6% vs 4.7% in the standard and sutureless groups; P = 0.364). The use of sutureless prostheses is advantageous and facilitates the adoption of a minimally invasive approach, reducing cardiac arrest time and the number of blood transfusions. No increased risk of permanent pacemaker insertion was observed.

Identifiants

pubmed: 33984125
pii: 6275393
doi: 10.1093/icvts/ivab070
pmc: PMC8691673
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

188-194

Subventions

Organisme : LivaNova

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Références

Interact Cardiovasc Thorac Surg. 2017 Oct 1;25(4):624-632
pubmed: 28962507
Eur J Cardiothorac Surg. 2016 Mar;49(3):978-86
pubmed: 26245628
Ann Thorac Surg. 2014 Aug;98(2):611-6; discussion 616-7
pubmed: 24928678
J Thorac Cardiovasc Surg. 2011 Dec;142(6):1577-9
pubmed: 21724194
Interact Cardiovasc Thorac Surg. 2017 Nov 1;25(5):818-821
pubmed: 29049755
Interact Cardiovasc Thorac Surg. 2014 Jul;19(1):21-6
pubmed: 24722513
N Engl J Med. 2020 Feb 27;382(9):799-809
pubmed: 31995682
J Thorac Cardiovasc Surg. 2013 Jan;145(1):6-23
pubmed: 23084102
Eur J Cardiothorac Surg. 2020 Apr 1;57(4):709-716
pubmed: 31647535
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
J Heart Valve Dis. 2012 Nov;21(6):732-9
pubmed: 23409353
Ann Thorac Surg. 2013 Jul;96(1):77-81; discussion 81-2
pubmed: 23673064
J Thorac Cardiovasc Surg. 2011 Dec;142(6):1453-7
pubmed: 21474151
Eur J Cardiothorac Surg. 2015 Jan;47(1):11-7; discussion 17
pubmed: 24599160
Ann Cardiothorac Surg. 2020 Sep;9(5):386-395
pubmed: 33102177
Interact Cardiovasc Thorac Surg. 2016 Aug;23(2):253-8
pubmed: 27160409
Int J Cardiol Heart Vasc. 2019 Apr 28;23:100362
pubmed: 31061875
Eur J Cardiothorac Surg. 2019 Oct 1;56(4):793-799
pubmed: 30820549
J Thorac Cardiovasc Surg. 2016 Jun;151(6):1617-1626.e4
pubmed: 26936009
Eur J Cardiothorac Surg. 2020 Nov 1;58(5):1063-1071
pubmed: 32588056
N Engl J Med. 2011 Jun 9;364(23):2187-98
pubmed: 21639811
J Thorac Cardiovasc Surg. 2015 Apr;149(4):1060-5
pubmed: 25680751

Auteurs

Domenico Paparella (D)

Department of Cardiac Surgery, Santa Maria Hospital, GVM Care & Research, Bari, Italy.
Dipartimento Scienze Medice e Chirurgiche, Università di Foggia, Foggia, Italy.

Giuseppe Santarpino (G)

Cardiac Surgery Unit, Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
Department of Cardiac Surgery, Klinikum Nürnberg, Paracelsus Medical University, Nuremberg, Germany.

Marco Moscarelli (M)

Department of Cardiac Surgery, Anthea Hospital, GVM Care & Research, Bari, Italy.

Pietro Guida (P)

Regional General Hospital "F. Miulli", Acquaviva delle Fonti, Italy.

Adriano De Santis (A)

Department of Cardiac Surgery, Santa Maria Hospital, GVM Care & Research, Bari, Italy.

Khalil Fattouch (K)

Department of Cardiac Surgery, Maria Eleonora Hospital, GVM Care & Research, Palermo, Italy.

Luigi Martinelli (L)

Department of Cardiac Surgery, ICLAS, GVM Care & Research, Rapallo, Italy.

Roberto Coppola (R)

Department of Cardiac Surgery, ICLAS, GVM Care & Research, Rapallo, Italy.

Elisa Mikus (E)

Department of Cardiac Surgery, Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.

Alberto Albertini (A)

Department of Cardiac Surgery, Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.

Mauro Del Giglio (M)

Department of Cardiac Surgery, Villa Torri Hospital, GVM Care & Research, Bologna, Italy.

Renato Gregorini (R)

Department of Cardiac Surgery, Città di Lecce Hospital, GVM Care & Research, Lecce, Italy.

Giuseppe Speziale (G)

Department of Cardiac Surgery, Anthea Hospital, GVM Care & Research, Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH